diazoxide and sildenafil citrate

diazoxide has been researched along with sildenafil citrate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Brito, GA; Gadelha, GG; Garcia, JA; Lima, SJ; Medeiros, JV; Ribeiro, RA; Santos, AA; Soares, PM; Souza, MH1
Araújo, PV; Clemente, CM; de Oliveira, RB; dos Santos, AA; Fernandes, GH; Magalhães, PJ; Palheta, RC; Ratts, ZM; Rola, FH1
Hasegawa, S; Kimura, S; Ohnishi, Y; Okada, S; Suzuki, Y; Yasudo, H1

Other Studies

4 other study(ies) available for diazoxide and sildenafil citrate

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats.
    British journal of pharmacology, 2008, Volume: 153, Issue:4

    Topics: Animals; Arginine; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Diazoxide; Disease Models, Animal; Enzyme Inhibitors; Ethanol; Gastric Mucosa; Glutathione; Glyburide; Guanylate Cyclase; Hemoglobins; KATP Channels; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Peptic Ulcer Hemorrhage; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Potassium Channel Blockers; Purines; Quinoxalines; Rats; Rats, Wistar; Signal Transduction; Sildenafil Citrate; Stomach Ulcer; Sulfones

2008
Sildenafil inhibits duodenal contractility via activation of the NO-K+ channel pathway.
    Fundamental & clinical pharmacology, 2008, Volume: 22, Issue:1

    Topics: Animals; Colforsin; Diazoxide; Duodenum; In Vitro Techniques; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Phosphodiesterase Inhibitors; Piperazines; Potassium Channel Blockers; Potassium Channels; Purines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Vasodilator Agents

2008
Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant.
    International heart journal, 2020, Sep-29, Volume: 61, Issue:5

    Topics: Atrial Natriuretic Factor; Beckwith-Wiedemann Syndrome; Cardiac Catheterization; Congenital Hyperinsulinism; Deprescriptions; Diazoxide; Diuretics; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Male; Natriuretic Peptide, Brain; Sildenafil Citrate; Vasodilator Agents

2020